Keyword: drug plan management

503 results found
WSIB drug changes shifted claims to other insurers: report

Ontario’s Workplace Safety and Insurance Board spent 33 per cent less on prescription drugs in 2015 than it did in 2010. The board has claimed the $34-million difference was due to lower drug prices and fewer claims entering the system. But a Toronto legal clinic is arguing the cost savings actually stem from reduced services to injured […]

  • By: Staff
  • May 24, 2017 September 13, 2019
  • 10:30
Plan sponsors bracing for onset of new orphan drugs

A year ago, the Association of Ontario Midwives Benefits Trust received its highest drug claim ever at $55,000 for a 12-week treatment of Harvoni, which treats hepatitis C. The plan deliberated whether it would fund the drug but it ultimately decided not to. “It was a very difficult decision,” says Nicole Mellin, executive director at […]

  • By: Jann Lee
  • May 9, 2017 September 13, 2019
  • 08:56
Days of ‘gravy train’ approach to drug plans at an end, says prof

The benefits industry often talks about the need for organizations to change the design of their drug plans, but how many of them are actually doing it? A professor at the University of British Columbia shed some light on the trends during the opening session at Benefits Canada’s Face to Face in Drug Plan Management […]

Plan members need help with co-ordinating care: report

The number of high-cost drugs and patients with multiple chronic conditions continues to rise, according to Express Scripts Canada’s drug trend report for 2016. While some plan sponsors have addressed increasing costs with measures such as generic pricing or limiting access to some drugs, the report suggested they should focus on providing certain plan members […]

  • By: Jann Lee
  • May 3, 2017 September 13, 2019
  • 08:43
Change to benefits plans urgent as cost pressures ‘only going to get worse’

Plan sponsors that have been hoping the recent trend of quickly rising drugs costs will end soon should realize “it’s only going to get worse” and start making changes to their benefits plans, an executive at Green Shield Canada said yesterday. “What’s happening right now is normal in benefit plans and it’s only going to […]

Ontario NDP puts forward universal pharmacare proposal

As Ontarians wait to see what’s in the provincial budget today, the Ontario New Democratic Party is getting ahead of the debate with its promise to implement a universal pharmacare plan should it win next year’s election. The NDP hopes the plan will ”reduce drug costs faced by individuals, businesses, municipalities, and other private payers; and increase […]

Shoppers launches new drug plan for employers

Loblaw Companies Ltd. is announcing the launch of HealthWatch for Business, a new drug plan that includes a formulary focused on savings from traditional, non-specialty medications. The plan, launched by the company’s Shoppers Drug Mart division, is targeting savings of five to 10 per cent in employer and employee costs. “We understand that employers are facing unprecedented […]

  • By: Staff
  • April 13, 2017 September 13, 2019
  • 10:02
Benefits innovation must strike a balance between convenience and risk

Innovation in the employee benefits world has historically happened in relatively small increments. Besides some subtle tweaks, plan design has changed very little. Recent enhancements to the employee experience include the implementation of online claims processing and various apps to communicate information more dynamically. Insurers have invested heavily in both their administration- and claims-paying systems to […]

What’s the role of doctors in boosting drug plan sustainability?

Some see it as an eternal struggle: the goodhearted doctor championing the best treatments, no matter the cost, while doing battle against the tightfisted insurance company denying claims for expensive but life-saving medications. But when you get down to it, their goals often dovetail: the best care for patients at affordable prices. After all, even […]

Drug Plan Trends Report: Alarm about costs sparks ‘monumental shift’

With drug plan costs back on the upswing amid unprecedented increases for stop-loss or pooling insurance, benefits advisors and insurers are seeing more plan sponsors voicing concerns over sustainability and showing a greater willingness to take actions beyond seeking the best rates at renewal time. “The industry is in the process of reacting to what’s […]